Evicita · Supplement evidence, graded and cited · Supplements · Lifestyle · Mechanisms · Lab tests · 中文

Uridine monophosphate (UMP)

Uridine Monophosphate (UMP) · also known as Uridylic acid, UMP, 5'-UMP, Kennedy brain nutrient triad core

Uridine is one of the building blocks cells use to make RNA and membrane phospholipids, and uridine monophosphate (UMP) is often used as a supplement. Animal studies show uridine can affect cholinergic and dopamine-related markers, but UMP’s effects on human memory and on brain neurotransmitters have not been confirmed.

Typical dose: 250–500 mg/day, taken in the morning or during periods of work or study
Absorption and forms: Free uridine is readily broken down in the gut and liver, while the disodium salt form of UMP is more water-soluble. But oral UMP is dephosphorylated and metabolized, so it cannot be claimed that the intact UMP molecule crosses the blood-brain barrier directly. Claims about sublingual use or very high absorption also lack reliable human data.

Clinical uses and human evidence

Peripheral neuropathy (numbness and tingling)

Mixed resultsGrade C · Preliminary evidence
Studies (1)
  1. Negrão 2016 · Pain Manag · Open-label study · n=48 — Uridine monophosphate, folic acid and vitamin B12 in patients with symptomatic peripheral entrapment neuropathies

Mechanisms of action

Cholinergic neurotransmission (ACh precursor supply and AChE inhibition)

★★★☆☆Mechanism evidence: grade CSecondary target

In animal experiments at exposures above typical human supplement levels, dietary UMP can increase striatal acetylcholine content and release. This suggests it may indirectly affect the cholinergic system through phospholipid metabolism. Dose and species differences are large, and human effects are not established.

References (1)
  1. Wang et al. 2007 · Rat study: dietary UMP at exposures above typical human supplement levels increased striatal acetylcholine content and release

Monoamine neurotransmitter balance (dopamine, norepinephrine, 5-HT)

★★☆☆☆Mechanism evidence: grade CSecondary target

Some animal studies suggest uridine-related substances affect dopamine transmission in the striatum, and some of these results came from UMP combined with DHA. The direction of change in dopamine receptor density and its significance in humans are not established, so it cannot be concluded that UMP alone improves human motivation or receptor sensitivity.

References (2)
  1. 2008 · Rat model: UMP combined with DHA affected dopamine transmission in damaged striatum
  2. 1988 · Rat study: chronic uridine treatment did not produce uniform D2 receptor upregulation

Neurotrophic factor synthesis and TrkB/A receptor activation

★★☆☆☆Mechanism evidence: grade DSecondary target

Nucleotides such as UTP can activate P2Y2 receptors, and in cell studies this receptor interacts with NGF/TrkA signaling. But these cell results cannot be extrapolated directly to UMP. There is currently no direct evidence on how UMP relates to the TrkB pathway, or on whether oral UMP changes BDNF and NGF signaling in humans.

References (2)
  1. Chorna et al. 2004 · Cell study: UTP activation of P2Y2 can change neurotrophin-related genes
  2. 2005 · Cell study: P2Y2 and NGF/TrkA signaling were found to interact

Safety and drug interactions

In a very small number of people, a large dose taken in the evening may cause enough alertness to interfere with falling asleep, so taking it in the morning or around midday is recommended.
Open in the interactive app ›